Potential impact of contaminated bronchoscopes on novel coronavirus disease (COVID-19) patients.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. A Review of Antibiotic Efficacy in COVID-19 Control.Journal of immunology research · 2023
   Review
2. Guidelines for Robotic Flexible Endoscopy at the Time of COVID-19.Frontiers in robotics and AI · 2021
   Review
3. Bronchoscopic procedures during COVID-19 pandemic: Experiences in Turkey.Journal of surgical oncology · 2020
   Article
4. Finding disease modules for cancer and COVID-19 in gene co-expression networks with the Core&Peel method.Scientific reports · 2020
   Article
5. Expert panel consensus statement on the applications and precaution strategies of bronchoscopy in patients with COVID-19.Endoscopic ultrasound
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as